Stay updated on t-PA Prophylaxis Clinical Trial

Sign up to get notified when there's something new on the t-PA Prophylaxis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the t-PA Prophylaxis Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:36:06.000Z thumbnail image
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    8 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study completion date for the pilot study testing the effectiveness of intra-catheter dwells of tissue plasminogen activator (t-PA) in decreasing central line associated blood stream infection (CLABSI) or venous thromboembolism (VTE) in central venous catheters (CVC) compared to standard of care heparin dwell.
    Difference
    0.1%
    Check dated 2024-06-06T14:24:51.000Z thumbnail image
  7. Check
    23 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for study participants, specifying age, PICU admission, and CVC placement requirements, along with general information about clinical research and eligibility criteria.
    Difference
    11%
    Check dated 2024-05-22T21:13:17.000Z thumbnail image
  8. Check
    45 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:48:59.000Z thumbnail image

Stay in the know with updates to t-PA Prophylaxis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the t-PA Prophylaxis Clinical Trial page.